One study found that a 5% to 10% reduction in body weight significantly reduced stress urinary incontinence episodes in obese women
Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes
Winelands Dermatology How our consultations work: Schedule Your Consultation: Reach out to our friendly team to book your appointment effortlessly
A Multicentre, Randomised, Double-Blind, Placebo Controlled, Phase II Study to Evaluate the Safety and Efficacy of Subcutaneous Bioresorbable Implants of Afamelanotide (CUV1647) for the Prophylactic Treatment of Pre-Cancerous Skin Lesions of the Head, Forearms and Hands in Immune Compromised, Organ Transplant Patients (Report)
According to the STEP 1 trial, the average weight loss at 68 weeks was 14.9% of body weight [1] on the 2.4mg maintenance dose
Those who took L-carnitine did much better than those who took the medication, particularly after receiving the supplement for 4 to 8 weeks